Share this:

CHI Memorial Offers New Procedure to Treat AFib

CHI Memorial, Chattanooga, TN, and The Chattanooga Heart Institute have a new treatment for people who have non-valvular atrial fibrillation (AFib). An estimated five million people in the U.S. are affected by AFib, an irregular heartbeat that brings a greater risk of stroke.

CHI Memorial now offers the implantation of a device that closes off the heart’s left atrial appendage (LAA). This may reduce the risk of stroke by keeping any blood clots that form in the LAA from entering the blood stream and potentially causing a stroke. Patients with the implanted device may be able to stop taking anticoagulants, which is helpful for patients who can’t tolerate blood-thinning medication long-term.

The device has already been implanted in more than 50,000 patients around the world. Implantation is a one-time procedure, and the device does not need replacement.

Understanding Vaccine Hesitancy in Communities of Color

MAR 04, 2021

CommonSpirit Health’s Alisahah Cole, MD, System Vice President Innovation and Policy Population Health, shares insights on why vaccine hesitancy may be more prevalent in communities of color.

READ MORE Additional information about Understanding Vaccine Hesitancy in Communities of Color

The Impact of COVID-19 in Communities of Color

MAR 04, 2021

Why are minority communities disproportionately impacted by COVID-19? Initial research indicates that socioeconomic factors are the primary contributor for the increased rate in minority communities.

READ MORE Additional information about The Impact of COVID-19 in Communities of Color

U.S. COVID-19 cases surpass 18 million

DEC 29, 2020

Dr. Thomas McGinn, executive vice president of Physician Enterprise, discussed the current state of the pandemic, the vaccine rollout, and growth in virtual care.

READ MORE Additional information about U.S. COVID-19 cases surpass 18 million